Inclusion body myositis (IBM) market is anticipated to grow at a significant CAGR during the forecast period. Inclusion body myositis is a rare condition and causes muscle weakness and damage. The symptoms of IBM include progressive weakness in muscles of the hand, forearm, thigh and lower leg, however, its symptoms vary and are not unique to this condition. The major factor driving the demand for the global Inclusion body myositis market is the increasing prevalence of IBM across the globe.
According to the National Organization for Rare Disorder, IBM affects males slightly more often than females. Additionally, it is estimated to be between 10-112 people per 1,000,000 in the general population. Moreover, it occurs at a higher rate in individuals more than 50 years of age. Additionally, it is estimated to be 51-139 per 1,000,000 individuals in the general population over 50 years of age. Hence, this makes IBM the most common acquired muscle disorder in the above 50 years, age group. Hence, the increasing prevalence of IBM is driving the growth of the market.
Some major players in the market include Abcuro, Inc., and Orphazyme ApS, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in January 2021, Abcuro announced that it has raised $42 million in a Sanofi Ventures co-led series A to advance anti-KLRG1 treatments for autoimmune diseases and cancers. The funding was aimed to run a proof-of-mechanism clinical trial in sporadic inclusion body myositis (IBM) patients.
To Request a Sample of our Report on Inclusion Body Myositis Market: https://www.omrglobal.com/request-sample/inclusion-body-myositis-market
Market Coverage
- The market number available for – 2021-2029
- Base year- 2021
- Forecast period- 2021-2029
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– Abcuro, Inc., and Orphazyme ApS, among others.
Inclusion Body Myositis Market Report by Segment
By Type
- ACE-083
- Aceneuramic Acid ER
- ALZ-1903
- UX-001P
- UX-007
- Others
By Application
- Hospital
- Clinic
- Others
A full Report of Inclusion Body Myositis Market is Available @ https://www.omrglobal.com/industry-reports/inclusion-body-myositis-market
Inclusion Body Myositis Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
